Advertisement

Clinical and Microbiological Aspects of Biofilm-Associated Surgical Site Infections

  • Charles E. EdmistonJr.Email author
  • Andrew J. McBain
  • Christopher Roberts
  • David Leaper
Chapter
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 830)

Abstract

While microbial biofilms have been recognized as being ubiquitous in nature for the past 40 years, it has only been within the past 20 years that clinical practitioners have realized that biofilm play a significant role in both device-related and tissue-based infections. The global impact of surgical site infections (SSIs) is monumental and as many as 80 % of these infections may involve a microbial biofilm. Recent studies suggest that biofilm- producing organisms play a significant role in persistent skin and soft tissue wound infections in the postoperative surgical patient population. Biofilm, on an organizational level, allows bacteria to survive intrinsic and extrinsic defenses that would inactivate the dispersed (planktonic) bacteria. SSIs associated with biomedical implants are notoriously difficult to eradicate using antibiotic regimens that would typically be effective against the same bacteria growing under planktonic conditions. This biofilm-mediated phenomenon is characterized as antimicrobial recalcitrance, which is associated with the survival of a subset of cells including “persister” cells. The ideal method to manage a biofilm-mediated surgical site wound infection is to prevent it from occurring through rational use of antibiotic prophylaxis, adequate skin antisepsis prior to surgery and use of innovative in-situ irrigation procedures; together with antimicrobial suture technology in an effort to promote wound hygiene at the time of closure; once established, biofilm removal remains a significant clinical problem.

Keywords

Surgical Site Infection Extracellular Polymeric Substance Periprosthetic Joint Infection Capsular Contraction Negative Pressure Wound Therapy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Akers KS, Mende K, Cheatle K, Zera WC, Yu X, Beckius ML, Aggarwal D, Carlos PL, Sanchez CJ, Wenke JC, Weintrob AC, Tribble DR, Murray CK (2014) Biofilms and persistent wound infections in United States military trauma patients a case-control analysis. BMC Infect Dis 14:190. http://www.biomedcentral.com/1471-2334/14/190
  2. Akiyama H, Ueda M, Kanwaki H, Tada J, Arata J (1997) Biofilm formation of Staphylococcus aureus strains isolated from impetigo and furuncle: role of fibrinogen and fibrin. J Dermatol Sci 16:2–10PubMedGoogle Scholar
  3. Alavi MR, Stojadinovic A, Izadjoo MJ (2012) An overview of biofilm and its detection in clinical samples. J Wound Care 21:376–383PubMedGoogle Scholar
  4. Allan N, Olson M, Nagel D, Martin R (2010) The impact of hydrosurgical debridement on wounds containing bacterial biofilms. Wound Repair Regen 18:A88Google Scholar
  5. American Society of Plastic Surgeon (2011) Plastic surgery procedural statistics. http://www.plasticsurgery.org.news-and-resources. Accessed 20 Jan 2013
  6. Andriesson AE, Eberlein T (2006) Assessment of a wound cleansing solution in the treatment of problem wounds. Wounds 20:171–175Google Scholar
  7. Armstrong PA, Bandyk (2006) Management of infected aortic grafts by in-situ grafting. In: Pearce WH, Matsumura JS, Yao JST (eds) Trends in vascular surgery 2005. Greenwood Academic, Evanston, pp 473–48Google Scholar
  8. Attinger C, Wolcott R (2012) Clinically addressing biofilm in chronic wounds. Adv Wound Care 1:127–132Google Scholar
  9. Back DA, Scheuermann-Poley C, Willy C (2013) Recommendations on negative pressure wound therapy with instillation and antimicrobial solutions – when, where and how to use: what does the evidence show? Int Wound J 10:32–42PubMedGoogle Scholar
  10. Bandyk DF, Black MR (2005) Infection in prosthetic vascular grafts. In: Rutherford RB, Johnson KW (eds) Vascular surgery, 6th edn. Elsevier Saunders, Philadelphia, pp 875–6894Google Scholar
  11. Barber KE, Werth BJ, McRoberts JP, Rybak MJ (2014) A novel approach utilizing biofilm time-kill curves to assess the bactericidal activity of ceftaroline combinations against biofilm-producing methicillin-resistant Staphylococcus aureus. Antimicrob Agent Chemother 58:2989–2992Google Scholar
  12. Barnes S, Spencer M, Graham D, Johnson HB (2014) Surgical wound irrigation: a call for evidence-based standardization of practice. Am J Infect Control 42:525–529PubMedGoogle Scholar
  13. Bauer JJ, Harris MT, Kreel I, Gelernt IM (1999) Twelve-year experience with expanded polytetrafluorethylene in the repair of abdominal wall defects. Mt Sinai J Med 66:20–25PubMedGoogle Scholar
  14. Bellon JM, Garcia-Carranza A, Garcia-Honduvilla N, Carrera-San Martin A, Bujan J (2004) Tissue integration and biomechanical behavior of contaminated experimental polypropylene and expanded polytetrafluoroethylene implants. Br J Surg 91:489–494PubMedGoogle Scholar
  15. Bigger JW (1944) Treatment of staphylococcal infection with penicillin. Lancet 2:497–500Google Scholar
  16. Birolini C, de Miranda JS, Utiyama EM, Rasslan S (2014) A retrospective review and observation over a 16-year clinical experience on the surgical treatment of chronic mesh infection. What about replacing a synthetic mesh on the infected surgical field? Hernia Feb 6 [Epub ahead of print]Google Scholar
  17. Bjarnsholt T, Kirketerp-Møller K, Jensen PØ, Madsen KG, Phipps R, Krogfelt K, Høiby N, Givskov M (2008) Why chronic wounds will not heal: a novel hypothesis. Wound Repair Regen 16:2–10PubMedGoogle Scholar
  18. Bondurant CP, Jimenez DF (1995) Epidemiology of cerebrospinal fluid shunting. Pediatr Neurosurg 23:254–258PubMedGoogle Scholar
  19. Braxton EE, Ehrlich GD, Hall-Stoodley L, Stoodley P, Veeh R, Fux C, Hu FZ, Quigley M, Post C (2005) Role of biofilms in neurological device-related infections. Neurosurg Rev 28:249–255PubMedGoogle Scholar
  20. Cameron T (2004) Safety and efficacy of spinal cord stimulation for the treatment of chronic pain: a 20-year literature review. J Neurosurg Spine 100:24–257Google Scholar
  21. Caputo WJ, Beggs DJ, DeFede JL, Simm L, Dharma H (2008) A prospective randomized controlled clinical trial comparing hydrosurgery debridement with conventional surgical debridement in lower extremity ulcers. Int Wound J 5:288–294PubMedGoogle Scholar
  22. Cardinal M, Eisenbud DE, Armstrong DG, Zelen C, Driver V, Attinger C, Phillips T, Harding K (2009) Serial surgical debridement: a retrospective study on clinical outcomes in chronic lower extremity wounds. Wound Repair Regen 17:306–311PubMedGoogle Scholar
  23. Centers for Disease Control and Prevention (2009) Ambulatory surgery in the United States, 2006, National Health Statistics Report, Number 11. http://www.cdc.gov/nchs/data/nhsr/nhsr011.pdf. Revised 4 September 2009
  24. Centers for Disease Control and Prevention (2010) National hospital discharge survey: 2010 table, procedures by selected patient characteristics – number by procedure category and age. http://www.cdc.gov/nchs/fastats/insurg.htm. Accessed 27 Aug 2013
  25. Cho KH, Caparon MG (2005) Patterns of virulence gene expression differ between biofilm and tissue communities of Streptococcus pyogenes. Mol Microbiol 57:1545–1556PubMedGoogle Scholar
  26. Costerton JW, Stewart PS (2001) Battling biofilms. Sci Am 285:74–81PubMedGoogle Scholar
  27. Costerton JW, Lewandowski Z, Caldwell DE, Korber DR, Lappin-Scott HM (1995) Microbial biofilms. Annu Rev Microbiol 49:711–745PubMedGoogle Scholar
  28. Costerton JW, Stewart PS, Greenberg EP (1999) Bacterial biofilms: a common cause of persisting infections. Science 284:1318–1322PubMedGoogle Scholar
  29. Cutting KF, Harding KG (1994) Criteria for identifying wound infection. J Wound Care 3:198–201Google Scholar
  30. Davidson CA, Lowe CR (2004) Optimization of polymeric surface pre-treatment to prevent bacterial biofilm formation for use in microfluidics. J Mol Recognit 25:2029–2037Google Scholar
  31. Davis LE, Cook G, Costerton JW (2002) Biofilm on ventriculoperitoneal shunt tubing as a cause of treatment failure in coccidioidal meningitis. Emerg Infect Dis 8:376–379PubMedCentralPubMedGoogle Scholar
  32. Davis SC, Ricotti C, Cazzaniga, Welsh E, Eaglstein WH, Mertz PM (2008) Microscopic and physiologic evidence for biofilm-associated wound colonization in vivo. Wound Repair Regen 16:23–29PubMedGoogle Scholar
  33. De Lissovoy G, Fraeman K, Hutchins V, Murphy D, Song D, Vaughn BB (2009) Surgical site infection: incidence and impact on hospital utilization and treatment costs. Am J Infect Control 37:387–397PubMedGoogle Scholar
  34. Del Pozo JL, Patel R (2009) Clinical practice. Infection associated with prosthetic joints. N Eng J Med 361:787–794Google Scholar
  35. Dissemond J, Assadian O, Gerber V, Kingsley A, Kramer A, Leaper DJ, Mosti G, Piatkowski DE, Grzymala A, Riepe G, Risse A, Romanelli M, Strohal R, Traber J, Vasel-Biergans A, Wild T, Eberlein T (2011) Classification of wounds at risk and their antimicrobial treatment with polyhexanide: a practice-oriented expert recommendation. Skin Pharmacol Physiol 24:245–255PubMedGoogle Scholar
  36. Donlan RM (2001a) Biofilm formation: a clinically relevant microbiological process. Clin Infect Dis 33:1387–1392PubMedGoogle Scholar
  37. Donlan RM (2001b) Role of biofilms in antimicrobial resistance. ASAIO J 46:547–552Google Scholar
  38. Dowd SE, Wolcott RD, Sun Y, McKeehan T, Smith E, Rhoads D (2008) Polymicrobial nature of chronic diabetic foot ulcer infections determined using bacterial tag encoded FLX amplicon pyrosequencing (bTEFAP). PLoS One 3:e3326PubMedCentralPubMedGoogle Scholar
  39. Dowsett C (2013) Biofilms: a practice-based approach to identification and treatment. Wounds UK 9:68–92Google Scholar
  40. Edds EM, Bergamini TM, Brittian KR, Kenneth R (2000) Bacterial components inhibit fibroblast proliferation in vivo. ASAIO J 46:33–37PubMedGoogle Scholar
  41. Edmiston CE (1993) Prosthetic device infections in surgery. In: Nichols RL, Nyhus LM (eds) Update surgical sepsis. JB Lippincott, Philadelphia, pp 444–468Google Scholar
  42. Edmiston CE, Seabrook GR, Cambria RA, Brown KR, Sommers JR, Krepel CJ, Wilson PJ, Sinski S, Towne JB (2005) Molecular epidemiology of microbial contamination in the operating room environment: is there a risk for infection? Surgery 138:572–588Google Scholar
  43. Edmiston CE, Seabrook GR, Goheen MP, Krepel CJ, Johnson CP, Lewis BD, Brown KR, Towne JB (2006a) Bacterial adherence to surgical sutures: can antimicrobial-coated sutures reduce the risk of microbial contamination? J Am Coll Surg 203:481–489PubMedGoogle Scholar
  44. Edmiston CE, Goheen MP, Seabrook GR, Johnson CP, Lewis BD, Brown KR, Towne JB (2006b) Impact of selective antimicrobial agents on staphylococcal adherence to biomedical devices. Am J Surg 192:344–354PubMedGoogle Scholar
  45. Edmiston CE, Krepel CJ, Marks RM, Rossi PJ, Sanger J, Goldblatt M, Graham MB, Rotherburger S, Collier J, Seabrook GR (2013a) Microbiology of explanted sutures segments from infected and non-infected surgical cases. J Clin Microbiol 51:417–421PubMedCentralPubMedGoogle Scholar
  46. Edmiston CE, Kiernan M, Leaper DJ (2013b) The Ying and Yang of pre-operative screening for methicillin sensitive Staphylococcus aureus (MSSA): would the extra effort and cost of decolonization reduce surgical site infections? Wound Med 1:7–12Google Scholar
  47. Edmiston CE, Daoud F, Leaper DJ (2013c) Is there an evidence-based argument for embracing an antimicrobial (triclosan)-coated suture technology to reduce the risk for surgical-site infections?: a meta-analysis. Surgery 154:89–100PubMedGoogle Scholar
  48. Edmiston CE, Bruden B, Rucinski M, Henen C, Graham MB, Lewis BL (2013d) Reducing the risk of surgical site infections: does chlorhexidine gluconate provide a risk reduction benefit? Am J Infect Control 41:S49–S55PubMedGoogle Scholar
  49. Edward R, Harding KG (2004) Bacteria and wound healing. Curr Opin Infect Dis 17:91–96Google Scholar
  50. Elek SD, Cohen PE (1957) The virulence of S. pyogenes for man: a study of the problems of wound infection. Br J Exp Pathol 38:573–586PubMedCentralPubMedGoogle Scholar
  51. Elgharaby H, Mann E, Awad H, Ganesh K, Ghatak PD, Gordillo G, Sai-Sudhakar CB, Sashwati R, Wozniak DJ (2013) First evidence of sternal wound biofilm following cardiac surgery. PLoS One 8:e70360Google Scholar
  52. Engelsman AF, van der Mei HC, Ploeg RJ, Busscher HJ (2007) The phenomenon of infection with abdominal wall reconstruction. Biomaterials 28:2314–2327PubMedGoogle Scholar
  53. Engelsman AF, van der Mei HC, Busscher HJ, Ploeg RJ (2008) Morphological aspects of surgical mesh as a risk factor for bacterial colonization. Br J Surg 95:1051–1059PubMedGoogle Scholar
  54. Evans LV, Lewandowski Z (2000) Structure and function of biofilms. In: Evans LV (ed) Biofilms: recent advances in their study and control. Harwood Academic, Amsterdam, pp 1–17Google Scholar
  55. Falanga V, Brem H, Ennis WJ, Wolcott R, Gould LJ, Ayello EA (2008) Maintenance debridement in the treatment of difficult-to-heal chronic wounds. Ostomy Wound Manag S2–S13Google Scholar
  56. Fernandes A, Dias M (2013) The microbiological profile of infected prosthetic implants with an emphasis on which organisms form biofilms. J Clin Diagn Res 7:219–223PubMedCentralPubMedGoogle Scholar
  57. Frei E, Hodgkiss-Harlow K, Rossi PJ, Edmiston CE, Bandyk DF (2011) Microbial pathogenesis of bacterial biofilms: a causative factor of vascular surgical site infection. Vasc Endovasc Surg 45:688–696Google Scholar
  58. Gardner SE, Frantz RA, Doebbeling BN (2001) The validity of the clinical signs and symptoms used to identify localized chronic wound infection. Wound Repair Regen 9:178–186PubMedGoogle Scholar
  59. Gilbert P, McBain AJ (2001) Biofilms: their impact on health and their recalcitrance toward biocides. Am J Infect Control 29:252–255PubMedGoogle Scholar
  60. Gilbert P, Maira-Litran T, McBain AJ, Rikard AH, Whyte FW (2002) The physiology and collective recalcitrance of microbial biofilm communities. Adv Microb Physiol 46:202–256PubMedGoogle Scholar
  61. Griffin JW, Guillot SJ, Redick JA, Browne JA (2012) Removed antibiotic-impregnated cement spacers in two-stage revision joint arthroplasty do not show biofilm formation in vivo. J Arthroplasty 27:1796–1799PubMedGoogle Scholar
  62. Gunnison JB, Fraher MA, Jawetz E (1964) Persistence of Staphylococcus aureus in penicillin in vitro. J Gen Microbiol 35:335–349PubMedGoogle Scholar
  63. Hall MR, McGillicuddy E, Kaplan LJ (2014) Biofilm: basic principles, pathophysiology, and implications for clinicians. Surg Infect 15:1–7Google Scholar
  64. Hall-Stoodley L, Costerton JW, Stoodley P (2004) Bacterial biofilms from the natural environment to infectious disease. Nat Rev Microbiol 2:95–108PubMedGoogle Scholar
  65. Hall-Stoodley L, Stoodley P, Kathju S, Høiby N, Moser C, Costerton JW, Moter A, Bjarnsholt T (2012) Towards diagnostic guidelines for biofilm-associated infections. FEMS Immunol Med Microbiol 65:127–145PubMedGoogle Scholar
  66. Hamy A, Pessaux P, Mucci-Hennekinne S, Radriamananjo A, Regenet N, Arnaud JP (2003) Surgical treatment of large incisional hernias by intraperitoneal Dacron mesh and an aponeurotic graft. J Am Coll Surg 196:531–534PubMedGoogle Scholar
  67. Harrison-Balestra C, Cazzaniga AL, Davis SC, Mertz PM (2003) A wound-isolated Pseudomonas aeruginosa grows a biofilm in vitro within 10 hours and is visualized by light microscopy. Dermatol Surg 29:631–635PubMedGoogle Scholar
  68. Hart JP, Eginton MT, Brown KR, Seabrook GR, Lewis BD, Edmiston CE, Towne JB, Cambria RA (2005) Operative strategies in aortic graft infections: is complete graft excision always necessary? Ann Vasc Surg 19:154–160PubMedGoogle Scholar
  69. Hasanadka R, Seabrook GR, Edmiston CE (2007) Vascular graft infections. In: Rello J, Vanes J, Kollef M (eds) Critical care infectious diseases. Kluwer Academic, Boston, pp 555–566Google Scholar
  70. Henry-Stanley MJ, Hess DJ, Barnes AMT, Dunny GM, Wells CL (2010) Bacterial contamination of surgical suture resembles a biofilm. Surg Infect 11:433–439Google Scholar
  71. Herwaldt LA, Cullen JJ, Scholz D, French P, Zimmerman MB, Pfaller MA, Wenzel RP, Pearl TM (2006) A prospective study of outcome, healthcare resource utilization, and cost associated with postoperative nosocomial infections. Infect Control Hosp Epidemiol 27:1291–1298PubMedGoogle Scholar
  72. Hoiby N, Ciofu O, Johansen HK, Song ZJ, Moser C, Jensen PO, Molin S, Givskov M, Tolker-Nielsen T, Bjarnsholt T (2011) The clinical impact of bacterial biofilms. Int J Oral Sci 3:55–65PubMedCentralPubMedGoogle Scholar
  73. Holland SP, Pulido JS, Miller D, Ellis B, Alfonso E, Scott M, Costerton JW (1991) Biofilm and scleral buckle-associated infections: a mechanism for persistence. Ophthalmology 98:933–938PubMedGoogle Scholar
  74. Hoyle B, Corsterton JW (1991) Bacterial resistance to antibiotics: the role of biofilm. Prog Drug Res 37:91–105PubMedGoogle Scholar
  75. Jacombs A, Tahir S, Hu H, Deva AK, Almatroudi A, Fick WL, Bradshaw DA, Vickery K (2014) In vitro and in vivo investigation of the influence if implant surface on the formation of bacterial biofilm in mammary implants. Plast Reconstr Surg 133:e471–e2475Google Scholar
  76. James GA, Swogger E, Wolcott R, Pulcini E, Secor P, Sestrich J, Costerton JW, Stewart PS (2008) Biofilms in chronic wounds. Wound Repair Regen 16:37–44PubMedGoogle Scholar
  77. Jayaraman R (2008) Bacterial persistence: some new insights into an old phenomenon. J Biosci 33:795–805PubMedGoogle Scholar
  78. Jenson PO, Givskov M, Bjarnsholt T, Moser C (2011) The immune system vs. Pseudomonas aeruginosa biofilms. FEMS Immunol Med Microbiol 59:292–305Google Scholar
  79. Kaehn K, Eberlein T (2009) In vitro test for comparing the efficacy of wound rinsing solutions. Br J Nurs 18:S4–S10PubMedGoogle Scholar
  80. Kathju S, Nistico L, Hall-Stoodley L, Post JC, Ehrlich GD, Stoodley P (2009) Chronic surgical site infection due to suture-associated polymicrobial biofilm. Surg Infect 10:457–461Google Scholar
  81. Kathju S, Lask LA, Nistico L, Colella JJ, Stoodley P (2010) Cutaneous fistula from gastric remnant resulting from chronic suture-associated biofilm infection. Obes Surg 20:251–256PubMedGoogle Scholar
  82. Kessler B, Sendi P, Graber P, Knupp M, Zwicky L, Hintermann B, Zimmerli W (2012) Risk factors for periprosthetic ankle joint infection: a case control study. J Bone Joint Surg Am 94:1871–1876PubMedGoogle Scholar
  83. Kim DH, Spencer M, Davidson SM, Li L, Shaw JD, Gulczynski D, Hunter DJ, Martha JF, Miley GB, Parazin SJ, Dejoie P, Richmond JC (2010) Institutional prescreening for detection and eradication of methicillin-resistant Staphylococcus aureus in patients undergoing elective orthopaedic surgery. J Bone Joint Surg 92:1820–1826PubMedGoogle Scholar
  84. Kingsley A (2001) A pro-active approach to wound infection. Nurs Stand 15:50–58PubMedGoogle Scholar
  85. Laffer RR, Graber P, Ochsner PE, Zimmerli W (2006) Outcome of prosthetic knee-associated infection: evaluation of 40 consecutive episodes at a single center. Clin Microbiol Infect 15:433–443Google Scholar
  86. Leaper D (2013) Silver dressings: their role in treatment of acute infected wounds. In: Willy C (ed) Antiseptics in surgery-update 2013. Lindqvist Book Publishing, Berlin, pp 151–154Google Scholar
  87. Leaper DJ, Meaume S, Apelqvist J, Teot L, Gottrup F (2011) Debridement methods of non-viable tissue in wounds. In: Farrar D (ed) Advanced wound repair therapies. Woodhead Publishers, CambridgeGoogle Scholar
  88. Leaper DJ, Ayello EA, Carville K, Fletcher J, Keast D, Lindholm C, Martinez JLL, Mavanini SD, McBain A, Moore Z, Opasanon S, Pina E (2012a) Appropriate use of silver dressings in wounds. International Consensus Document, LondonGoogle Scholar
  89. Leaper DJ, Schultz G, Carville K, Fletcher F, Swanson T, Drake R (2012b) Extending the TIME concept: what have we learned in the past 10 years? Int Wound J 9:1–19PubMedGoogle Scholar
  90. Leber GE, Garb JL, Alexander AI, Reed WP (1998) Long-term complications associated with prosthetic repair of incisional hernias. Arch Surg 133:378–382PubMedGoogle Scholar
  91. Leid JG, Wilson CJ, Shirtliff ME, Hassett DJ, Parsek MR, Jeffers AK (2005) The exopolysaccharide alginate protects biofilm from IFN-gamma-mediated macrophage killing. J Immunol 175:7512–7518PubMedGoogle Scholar
  92. Lozier AP, Sciacca RR, Romagnoli MF, Connolly ES (2002) Ventriculostomy-related infections; a critical review of the literature. Neurosurgery 51:170–181PubMedGoogle Scholar
  93. Luijendiik RW, Hop WCJ, van der Tol MP, de Lange DCD, Braaksma MMJ, Ijzermans JNM, Boelhouwer RU, de Vries BC, Salu MK, Wereldsma JC, Bruijninckx CM, Jeekel J (2000) A comparison of suture repair and mesh repair for incisional hernia. N Engl J Med 343:392–398Google Scholar
  94. Machairas A, Misiakos EP, Liakakos T, Karatzas G (2004) Incisional hernioplasty with extraperitoneal on-lay polyester mesh. Ann Surg 70:726–729Google Scholar
  95. Mah TF, O’Toole GA (2001) Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol 9:34–39PubMedGoogle Scholar
  96. Massie JB, Heller JG, Abitbol JJ, McPherson D, Garfin SR (1992) Postoperative posterior spinal wound infections. Clin Orthop 284:99–108PubMedGoogle Scholar
  97. Mauermann WJ, Sampathkumar P, Thompson RL (2008) Sternal wound infections. Best Pract Clin Anesthesiol 22:423–436Google Scholar
  98. Meier-Davis S (2006) Host response to biofilms, foreign implants and devices. In: Pace JL, Mark E, Rupp Roger GF (eds) Biofilms, infection and antimicrobial therapy. Taylor & Francis Group, Boca Raton, pp 315–317Google Scholar
  99. Ming X, Nichols M, Rothenburger S (2007) In-vivo antibacterial efficacy of Monocryl Plus® antibacterial (poliglecaprone 25 with triclosan) suture. Surg Infect (Larchmt) 8:1–5Google Scholar
  100. Mosti G, Iabichella ML, Picerni P, Magliaro A, Mattaliano V (2005) The debridement of hard to heal leg ulcers by means of a new device based on Fluid jet technology. Int Wound J 2:307–314PubMedGoogle Scholar
  101. Nahabedian MY, Tsangaris T, Momen B, Manson PN (2003) Infectious complications following breast reconstruction with expanders and implants. Plast Reconstr Surg 112:467–476PubMedGoogle Scholar
  102. National Institute of Health (2002) Research on microbial biofilms: PA Number: PA-03-047. http://grants.nih.gov/grants/guide/pa-files/PA-03-047.html
  103. National Institute for Health and Clinical Excellence (2013) NICE medical technology scope: Debrisoft for the debridement of acute and chronic wounds. Available at: www.nice.org.uk/nicemedia/live/14185/64407/64407.pdf
  104. Nemoto K, Hirota K, Ono T, Murakami K, Nagao D, Miyake Y (2000) Effect of varidase (streptokinase) on biofilm formed by Staphylococcus aureus. Chemotherapy 46:111–115PubMedGoogle Scholar
  105. Neto A, Lozano M, Moro MT, Keller J, Carralafuenta C (2002) Determinants of wound infection after surgery for breast cancer. Zentralbl Gynakol 124:429–433Google Scholar
  106. Netscher DT (2004) Subclinical infection as a possible cause of significant breast capsules. Plast Reconstr Surg 113:2229–2230PubMedGoogle Scholar
  107. Olsen MA, Chu-Ongsakul S, Brandt KE, Dietz JR, Mayfield J, Fraser VJ (2008) Hospital-associated cost due to surgical site infection after breast surgery. Arch Surg 143:53–56PubMedGoogle Scholar
  108. Otto M (2008) Staphylococcal biofilm. Curr Top Microbiol Immunol 322:207–228PubMedCentralPubMedGoogle Scholar
  109. Owen S, Ramraj V, Wallop J (2010) The cardiac surgery advance practice group: a case study of APN and PA collaborative practice. J Nurs Pract 6:371–374Google Scholar
  110. Pandey R, Berendt AR, Athanasou NA (2000) Histological and microbiological findings in non-infected and infected revision arthroplasty tissue. The OSIRIS Collaborative Study Group, Oxford Skeletal Infection Research and Intervention Service. Arch Orthop Trauma Surg 120:570–574PubMedGoogle Scholar
  111. Parsa K, Schaudinn C, Gorur A, Sedghizadeh PP, Johnson T, Tse DT, Costerton JW (2010) Demonstration of bacterial biofilms in culture-negative silicone stent and jones tubes. Ophthal Plast Reconstr Surg 26:426–430PubMedGoogle Scholar
  112. Parsek MR, Greenberg EP (2005) Sociomicrobiology – the connection between quorum sensing and biofilms. Trends Microbiol 13:27–33PubMedGoogle Scholar
  113. Percival SL (2004) Biofilms and their potential role in wound healing. Wound 16:234–240Google Scholar
  114. Percival SL (2011) Biofilms and their management: form concept to clinical reality. J Wound Care 20:220–226Google Scholar
  115. Percival SL, Thomas JG, Williams DW (2010) Biofilms and bacterial imbalances in chronic wounds: anti-Koch. Int Wound J 7:169–175PubMedGoogle Scholar
  116. Percival SL, Hill KE, Williams DW, Hooper SJ, Thomas DW, Costerton JW (2012) A review of the scientific evidence for biofilms in wounds. Wound Repair Regen 20:647–657PubMedGoogle Scholar
  117. Phillips PL, Wolcott RD, Fletcher J, Schultz GS (2010a) Biofilms made easy. Wounds Int 1:1–6Google Scholar
  118. Phillips PL, Yang Q, Sampson E, Schultz G (2010b) Effects of antimicrobial agents on an in vitro biofilm model of skin wounds. Adv Wound Care 1:299–304Google Scholar
  119. Raju DR, Jindrak K, Weiner M, Enquist IF (1977) A study of the critical bacterial inoculums to cause a stimulus to wound healing. Surg Gynecol Obstet 144:347–350PubMedGoogle Scholar
  120. Ray JM, Triplett G (2011) What is the role of biofilms in severe head and neck infections? Oral Maxillofac Surg Clin North Am 23:497–505PubMedGoogle Scholar
  121. Reed D, Kemmerly SA (2009) Infection control and prevention: a review of hospital-acquired infections and the economic implications. Ochsner J 9:27–31PubMedCentralPubMedGoogle Scholar
  122. Rhoads DD, Wolcott RD, Percival SL (2008) Biofilms in wounds management strategies. J Wound Care 17:502–508PubMedGoogle Scholar
  123. Rieger UM, Kalbermatten DF, Haug M, Frey HP, Pico R, Frei R, Pierer G, Luscher NJ, Trampuz A (2013) Bacterial biofilms and capsular contracture in patients with breast implants. Br J Surg 100:768–774PubMedGoogle Scholar
  124. Romling U, Balsalobre C (2012) Biofilm infections, their resilience to therapy and innovative treatment strategies. J Intern Med 272:541–561PubMedGoogle Scholar
  125. Rothenburger S, Spangler D, Bhende S, Burkley D (2002) In-vitro antimicrobial evaluation of coated Vicryl Plus antibacterial suture (coated polyglactin 910 with triclosan) using zone of inhibition assay. Surg Infect 3:S79–S87Google Scholar
  126. Samini DB, Bielory BP, Miller D, Johnson TE (2013) Microbiologic trends and biofilm growth on explanted periorbital biomaterials: a 30-year review. Opthal Plast Reconstr Surg 29:376–381Google Scholar
  127. Sanchez CJ, Mende K, Beckius ML, Akers KS, Romano DR, Wenke JC, Murray CK (2013) Biofilm formation by clinical isolates and the implication in chronic infections. BMC Infect Dis 13:47. http://www.biomedcentral.com/1571-2334/13/47
  128. Sauer K, Camper AK, Ehrlich GD, Costerton JW, Davies DG (2002) Pseudomonas aeruginosa displays multiple phenotypes during development as a biofilm. J Bacteriol 184:1140–1154PubMedCentralPubMedGoogle Scholar
  129. Scott NW, McCormack K, Graham P, Go PM, Ross SJ, Grant AM (2002) Open mesh versus non-mesh repair for femoral and inguinal hernia. Cochrane Database Syst Rev CD002197Google Scholar
  130. Seaton RA, Malizos KN, Viale P, Gargalianos-Kakolyris P, Santantonio T, Petrelli E, Pathan R, Heep M, Chaves R (2013) Daptomycin use in patients with osteomyelitis: a preliminary report from the EU-COREsm database. J Antimicrob Chemother 68:1642–1649PubMedCentralPubMedGoogle Scholar
  131. Shepard J, Ward W, Milstone A, Carlson T, Frederick J, Hadhazy E, Perl T (2013) Financial impact of surgical site infections on hospital: the hospital management perspective. JAMA Surg. doi: 10.1001/jamasurg.2013.2246 PubMedGoogle Scholar
  132. Sibbald RG, Leaper DJ, Queen D (2011) Iodine made easy. Wounds Int 2:s1–s6Google Scholar
  133. Singh PK, Parsek MR, Greenberg EP, Welsh MJ (2002) A component of innate immunity prevents bacterial biofilm development. Nature 417:552–555PubMedGoogle Scholar
  134. Spoering AL, Lewis K (2001) Biofilms and planktonic cells of Pseudomonas aeruginosa has similar resistance to killing by antimicrobial. J Bacteriol 183:6746–6751PubMedCentralPubMedGoogle Scholar
  135. Steckelberg JM, Osmom DR (2000) In: Waldvogel FA (ed) Prosthetic joint infection: infections associated with indwelling medical devices, 3rd edn. ASM Press, Washington, DC, pp 173–205Google Scholar
  136. Stewart PS, Costerton JW (2001) Antibiotic resistance of bacteria in biofilms. Lancet 358:135–138PubMedGoogle Scholar
  137. Stoodley P, Sauer K, Davies DG, Costerton JW (2002) Review. Biofilms as complex differentiated communities. Annu Rev Microbiol 56:187–209PubMedGoogle Scholar
  138. Subramani K, Jung RE, Molenberg A, Hammerle CH (2009) Biofilm on dental implants: a review of the literature. Int J Oral Maxillofac Implants 24:616–626PubMedGoogle Scholar
  139. Sugita J, Yokoi N, Fullwood NJ, Quantock AJ, Takada Y, Nakamura Y, Kinoshita S (2001) The detection of bacterial biofilms in punctual plug holes. Cornea 20:362–365PubMedGoogle Scholar
  140. Sun Y, Dowd SE, Smith E, Rhoads DD, Walcott RD (2008) In vitro multispecies Lubbock chronic wound biofilm model. Wound Repair Regen 16:805–813PubMedGoogle Scholar
  141. Tran CL, Langer S, Broderick-Villa G, DiFronzo LA (2002) Does reoperation predispose to postoperative wound infection in women undergoing operation for breast cancer? Am Surg 69:852–856Google Scholar
  142. Tsoi B, Ziolkowoski NI, Thoma A, Campbell K, O’Reilly D, Goeree R (2014) Safety of tissue expander/implant versus autologous abdominal tissue breast reconstruction in postmastectomy breast cancer patients: a systematic review and meta-analysis. Plast Reconstr Surg 133:234–249PubMedGoogle Scholar
  143. Umemura A, Jaggi JL, Hurthi HI, Siderowf AD, Colcher A, Stern MB, Baltuch GH (2003) Deep brain stimulation for movement disorder: morbidity and mortality in 109 patients. J Neurosurg 98:779–784PubMedGoogle Scholar
  144. Vandeweyer E, Deraemaecker R, Nogaret JM, Hertens D (2003) Immediate breast reconstruction with implants and adjuvant chemotherapy: a good option? Acta Chir Belg 103:98–101PubMedGoogle Scholar
  145. Vanwijck R, Kaba L, Boland S, Gonzales y Azero M, Delange A, Tourbach S (2010) Immediate skin grafting of sub-acute and chronic wounds debrided by hydrosurgery. J Plast Reconstr Aesthet Surg 63:544–549PubMedGoogle Scholar
  146. Varma S, Ferguson HC, Breen DV, Lumb WV (1974) Comparison of seven suture materials in infected wounds: an experimental study. J Surg Res 17:165–170PubMedGoogle Scholar
  147. Walker TS, Tomlin KL, Woethern GS, Poch KR, Lieber JG, Saavedra MT, Fessler MB, Malcolm KC, Vasil ML, Nick JA (2005) Enhanced Pseudomonas biofilm development mediated by human neutrophils. Infect Immun 73:3693–3701PubMedCentralPubMedGoogle Scholar
  148. White W (2011) Sharp wound debridement in the management of recalcitrant, locally infected chronic venous leg ulcers: a narrative review. Wound Pract Res 19:222–228Google Scholar
  149. Williams DL, Costerton JW (2012) Using biofilms as initial inocula in animal models of biofilm-related infections. J Biomed Mater Res B Appl Biomater 100:1163–1169PubMedGoogle Scholar
  150. Wolcott RD, Cox S (2013) More effective cell-based therapy through biofilm suppression. J Wound Care 22:26–31PubMedGoogle Scholar
  151. Wolcott RD, Rhoads DD (2008) A study of biofilm-based wound management in subjects with critical limb ischemia. J Wound Care 17:145–155PubMedGoogle Scholar
  152. Wolcott RD, Rhoads D, Dowd SE (2008) Biofilms and chronic wound inflammation. J Wound Care 17:333–341PubMedGoogle Scholar
  153. Wolcott RD, Kennedy JP, Dowd SE (2009) Regular debridement is the main tool for maintaining a healthy wound bed in most chronic wounds. J Wound Care 18:54–56PubMedGoogle Scholar
  154. Wolcott RD, Rhoads DD, Bennett ME, Wolcott BM, Gogokhia L, Costerton JW, Dowd SE (2010a) Chronic wounds and the medical biofilm paradigm. J Wound Care 19:45–53PubMedGoogle Scholar
  155. Wolcott RD, Rumbaugh KP, Stewart PS, Dowd SE (2010b) Biofilm maturity studies indicate sharp debridement opens a time-dependent therapeutic window. J Wound Care 19:320–328PubMedGoogle Scholar
  156. Wood HL, Holden SR, Bayston R (2001) Susceptibility of Staphylococcus epidermidis biofilm in CSF shunts to bacteriophage attack. Eur J Pediatr Surg 11:S56–S57PubMedGoogle Scholar
  157. Zhao G, Usui ML, Lippmann SI, James GA, Stewart PS, Fleckman P, Olerud JE (2013) Biofilms and inflammation in chronic wounds. Adv Wound Care 2:389–399Google Scholar
  158. Zimmerli W, Moser C (2012) Pathogenesis and treatment concepts of orthopedic biofilm infections. FEMS Immunol Med Microbiol 65:158–168PubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2015

Authors and Affiliations

  • Charles E. EdmistonJr.
    • 1
    Email author
  • Andrew J. McBain
    • 2
  • Christopher Roberts
    • 3
  • David Leaper
    • 4
  1. 1.Department of SurgeryMedical College of WisconsinMilwaukeeUSA
  2. 2.Manchester Pharmacy SchoolThe University of ManchesterManchesterUK
  3. 3.Clinical ResolutionsHessleUK
  4. 4.School of Applied SciencesUniversity of HuddersfieldHuddersfieldUK

Personalised recommendations